3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Ovarian Neoplasms
19
Neoplasms
12
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
11
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Digestive System Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Mouth Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Astrocytoma
2
Interventions
Carboplatin
11
atezolizumab
10
Etoposide
9
durvalumab
6
Topotecan
6
PM 01183
6
Specimen Handling
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Irinotecan
2
Injections
2
Drug Therapy
2
Cisplatin
2
Biopsy
2
AMG 757
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
berzosertib
1
avelumab
1
arginine decarboxylase
1
amrubicin
1
Vaccines
1
Taxes
1
Sodium Chloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Bevacizumab
×
30 days
×
Clear all
No trials found.